Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma

Published:2021-09 Issue: Volume:337 Page:179-192
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Sharma Rishi,Liaw Kevin,Sharma Anjali,Jimenez Ambar,Chang Michelle,Salazar Sebastian,Amlani Imaan,Kannan Sujatha,Kannan Rangaramanujam M.

Funder

National Institute of Neurological Disorders and Stroke

National Institutes of Health

National Eye Institute

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference79 articles.

1. Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme;Ung;J. Neuro-Oncol.,2015

2. Glioblastoma multiforme: a review of where we have been and where we are going;Adamson;Expert Opin. Investig. Drugs,2009

3. Glioblastoma and other malignant gliomas: a clinical review;Omuro;JAMA,2013

4. Malignant gliomas in adults;Wen;N. Engl. J. Med.,2008

5. Fatigue among patients with brain tumors;Asher;CNS Oncol,2016

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solubilization techniques used for poorly water-soluble drugs;Acta Pharmaceutica Sinica B;2024-09

2. Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment;Biomedicines;2024-08-11

3. A review on dendrimer-based nanoconjugates and their intracellular trafficking in cancer photodynamic therapy;Artificial Cells, Nanomedicine, and Biotechnology;2024-08-05

4. Glycosylation: mechanisms, biological functions and clinical implications;Signal Transduction and Targeted Therapy;2024-08-05

5. Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade;Archiv der Pharmazie;2024-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3